Putting the Face to a Name Concurrent Assessment of Vascular Morphology and Biology by Dilsizian, Vasken & Narula, Jagat
EP
C
V
W
d
n
p
n
p
c
c
d
l
t
p
o
a
a
s
a
d
c
i
i
t
m
p
u
o
i
i
i
m
v
F
M
J A C C : C A R D I O V A S C U L A R I M A G I N G V O L . 2 , N O . 1 0 , 2 0 0 9
© 2 0 0 9 B Y T H E A M E R I C A N C O L L E G E O F C A R D I O L O G Y F O U N D A T I O N I S S N 1 9 3 6 - 8 7 8 X / 0 9 / $ 3 6 . 0 0
P U B L I S H E D B Y E L S E V I E R I N C . D O I : 1 0 . 1 0 1 6 / j . j c m g . 2 0 0 9 . 0 8 . 0 0 5D I T O R ’ S P A G E
utting the Face to a Name
oncurrent Assessment of Vascular Morphology and Biology
asken Dilsizian, MD,* Jagat Narula, MD, PHD†f
b
n
c
o
v
d
u
a
o
b
(
p
a
a
n
m
o
n
a
m
l
t
a
t
A
t
t
p
p
a
n
o
f
P
tith the hybrid positron emission to-
mography (PET) and computed tomo-
graphy (CT) systems, coronary artery
anatomy and physiology can be realized
uring the same imaging session. Whereas the coro-
ary CT angiography provides information on the
resence and extent of the luminal stenosis in coro-
ary artery disease (CAD), PET blood flow tracers
rovide information on the downstream functional
onsequence of these lesions. Current clinical appli-
ations of these imaging studies are focused pre-
ominantly on the identification of coronary artery
esions, which can be treated by coronary interven-
ions. With the evolving technology, CT angiogra-
hy may allow interrogation of the plaque morphol-
gy beyond the assessment of the luminal stenosis
nd the new radio-labeled ligands may expand the
pplication of PET to assess plaque biology and in-
tability. This is particularly relevant in asymptom-
tic subjects with coronary risk factors in whom the
iagnosis often remains elusive before the actual oc-
urrence of an acute coronary event. Accordingly, an
mportant driver for the hybrid cardiac PET-CT
maging will likely come from a paradigm shift in
he health care delivery from diagnosis and treat-
ent to prediction and prevention of disease.
The cost-effectiveness of cardiac prevention is
erceived to be so large that the number of individ-
als to be considered for lipid lowering, even based
n the well-accepted guidelines, exceeds 50 million
n the U.S. alone (1). It is expected that with imag-
ng of the atherosclerotic plaque for risk assessment,
t would become possible to adjust medical therapy
ore closely to the subjects’ actual needs and pre-
ent unnecessary health care costs. The clinical use-c
rom the *University of Maryland School of Medicine, Baltimore,
aryland; and the †University of California-Irvine, Irvine, California.ulness of such a strategy can be better appreciated
ecause at least 50% of acute coronary events origi-
ate in coronary arteries that do not reveal signifi-
ant angiographic stenosis. Regardless of the severity
f luminal obstruction, the culprit plaques in the
ictims of acute coronary events histopathologically
emonstrate larger plaque and necrotic core vol-
mes, greater necrotic core-to-plaque volume ratio,
nd usually significant positive remodeling at the site
f vascular involvement; these plaques are covered
y thin fibrous caps and are substantially inflamed
2). The characteristic structural features of such
laques have been noninvasively described by CT
ngiographic imaging in patients presenting with
cute coronary events. The most important determi-
ants of plaque instability included positive re-
odeling and low attenuation plaques (suggestive
f necrotic cores) (3). Identification of such coro-
ary lesions in the absence of an event predicts
lmost a 25-fold higher likelihood for develop-
ent of an acute coronary event over the fol-
ow-up of 2 years as compared with a not posi-
ively remodeled plaque of intermediate or higher
ttenuation (4). The larger the plaque volume or
he necrotic core area, the earlier an event occurred.
lthough the tools that identify the structural fea-
ures of the plaques predict a greater vulnerability,
hey fail to identify the critical component of the
laque instability (i.e. inflammation).
Radionuclide tracers, by their nature, reflect
athophysiologic processes at the subcellular level
nd have been employed for the detection of immu-
oinflammatory infiltrates. F18-labeled 2-fluorode-
xyglucose (FDG) has been most commonly used
or this purpose. The FDG uptake as assessed by
ET correlated closely with the extent of inflamma-
ion in the carotid endarterectomy specimens and
an be assessed serially to monitor the efficacy of
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1244reatment (5). The FDG imaging was not easily
easible in the coronary vessels because of a lower
esolution of the PET-based imaging techniques. A
ecent report has vividly demonstrated that a hybrid
ET-CT imaging allowed the localization of coro-
ary inflammatory activity (6). The increased FDG
ptake is expected to occur in metabolically active
ells including the cells of monocyte–macrophage
rigin in the unstable plaques. A study in this issue
f iJACC, targets a more specific process of expres-
ion of adhesion molecules on the vascular endothe-
ial cells. This study employs the combined virtues
f structural and functional imaging (7).
Integrating the synergistic information that ex-
sts between PET and CT to characterize coro-
ary plaques would allow better disease definition,Arithmetic of vulnerable plaques for Narula J. Clinical fend individualized monitoring of response to
reatment. Arguably, this is one of the most excit-
ng fields in cardiovascular medicine, and the tra-
ectory for future growth of targeted molecular
maging with PET-CT for characterizing inflam-
atory atherosclerosis seems boundless. Better
efinition and localization of the functional activ-
ty is similar to the proverbial expression of put-
ing the face to a name!
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